
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is an early commercial stage biopharmaceutical company focused on developing and commercializing best-in-class products. Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. Our management team has extensive expertise in the development and commercialization of medical dermatology products, having held key leadership roles at a number of leading dermatology companies and, collectively, has successfully developed more than 50 FDA-approved products. We believe that...
Biotechnology,medical dermatology,drug development,inflammation,immunology,clinical trials,topical drugs,bioscience,commercialization,plaque psoriasis,atopic dermatitis,and eczema
Arcutis biotherapeutics, inc. (nasdaq: arqt) operates in the Biotechnology research industry.
Arcutis biotherapeutics, inc. (nasdaq: arqt)'s revenue is 101m - 500m
Arcutis biotherapeutics, inc. (nasdaq: arqt) has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.